Christopher J.L. Murray and Jennifer Kates discuss disease from the perspective of shaping U.S. policy, spending priorities, and potential action.

Thomas Bollyky, CFR's senior fellow for global health, economics, and development, leads a discussion on the rise of noncommunicable diseases in the developing world, attitudes towards them, and solutions for addressing them.

James Habyarimana, Matthew L. Myers, and Bernhard Weigl discuss scalable and practical strategies developing countries can use to address the global health challenges of noncommunicable diseases. This session is part two of the two session meeting, Noncommunicable Diseases and the New Global Health.

Experts discuss scalable and practical strategies developing countries can use to address the global health challenges of noncommunicable diseases.

This session is part two of the two session meeting, Noncommunicable Diseases and the New Global Health.

Experts discuss scalable and practical strategies developing countries can use to address the global health challenges of noncommunicable diseases.

This session is part two of the two session meeting, Noncommunicable Diseases and the New Global Health.

Thomas R. Frieden, director of U.S. Centers for Disease Control and Prevention and administrator of the Agency for Toxic Substances and Disease Registry, discusses the challenges facing low- and middle-income countries in combating noncommunicable diseases.

This session is part one of the two session meeting, Noncommunicable Diseases and the New Global Health.

Yanzhong Huang discusses China's expanding list of unsafe food products, failures in its regulation of food, and its need for serious reform.

CFR's Senior Fellow for Global Health Laurie Garrett and Science correspondent Jon Cohen discuss the XIX International AIDS Conference, summarize the "good news" and the "bad news" coming out of the conference, and examine the challenges that still remain in the fight against AIDS.

The International AIDS Conference shows that challenges, such as funding and maintaining political will, likely means no short-term end to the epidemic, says CFR's Laurie Garrett.

Michael W. Hodin says the global forecast for Alzheimer's is not good, arguing, "If we don't make significant strides in prevention, treatment and cures, Alzheimer's will turn the miracle of longevity into a society-wide curse."

Efforts to vaccinate Pakistani children are in peril after the CIA's vaccine ploy to help capture Osama bin Laden, placing the entire region at risk of outbreaks, says CFR's Laurie Garrett.

Peter Piot and Michel Sidibé discuss Piot's new book, No Time to Lose: A Life in Pursuit of Deadly Viruses, the Joint United Nations Programme on HIV/AIDS, and the state of the AIDS epidemic in the world today.

Peter Piot and Michel Sidibé discuss Piot's new book, No Time to Lose: A Life in Pursuit of Deadly Viruses, the Joint United Nations Programme on HIV/AIDS, and the state of the AIDS epidemic in the world today.

Laurie Garrett examines whether the CIA ruined the chance to eradicate polio worldwide.

Laurie Garrett reviews Peter Piot's No Time to Lose: A Life in Pursuit of Deadly Viruses.

Laurie Garrett and Steven A. Cook discuss the threats of Avian flu and foot and mouth disease in Egypt.

An examination of the World Bank's evolution as a global health actor and Jim Yong Kim's career in public health raises questions about how he would handle the role of president, writes CFR's Laurie Garrett.

Laurie Garrett says the Global Fund's drive to ensure sustainability and efficiency means that it may not be able to meet its commitments to combat disease.

Experts discuss current global vaccination efforts in conjunction with the launch of CFR's Vaccine-Preventable Outbreak Interactive Map.

In their single-minded pursuit of economic growth, China's leaders have long overlooked public health—which, by some measures, is now worse than under Mao.